• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
    January 21, 2019
    JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald.
  • JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
    January 21, 2019
    JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald.
  • JW Pharmaceutical invests in British anti-cancer drugs developer pharmaceutical-technology
    October 30, 2018
    South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service